1-3 of 3
Pieter R. Cullis
Close
Sort by
Journal Articles

Suppression of fibrin(ogen)-driven pathologies in disease models through controlled knockdown by lipid nanoparticle delivery of siRNA

Lih Jiin Juang, Woosuk S. Hur, Lakmali M. Silva, Amy W. Strilchuk, Brenton Francisco, Jerry Leung, Madelaine K. Robertson, Dafna J. Groeneveld, Bridget La Prairie, Elizabeth M. Chun, Andrew P. Cap, James P. Luyendyk, Joseph S. Palumbo, Pieter R. Cullis, Thomas H. Bugge, Matthew J. Flick, Christian J. Kastrup
Journal: Blood
Blood (2022) 139 (9): 1302–1311.
https://doi.org/10.1182/blood.2021014559
Published: 2022
Journal Articles

Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency

Amy W. Strilchuk, Scott C. Meixner, Jerry Leung, Nooshin S. Safikhan, Jayesh A. Kulkarni, Hannah M. Russell, Roy van der Meel, Michael R. Sutherland, A. Phillip Owens, III, Joseph S. Palumbo, Edward M. Conway, Edward L. G. Pryzdial, Pieter R. Cullis, Christian J. Kastrup
Journal: Blood
Blood (2020) 136 (25): 2946–2954.
https://doi.org/10.1182/blood.2020004976
Published: 2020
Includes: Supplemental data
Journal Articles

Marqibo (Vincristine Sulfate Liposomes Injection, OPTISOME™) Concentrates Vincristine in Tumor Tissue and Lymphoid Malignancy Oriented Tissues in Tumor-Bearing Mice.

Pieter R. Cullis, Hagop Kantarjian, Frederick Appelbaum, Susan O’Brien, May Wong, Gavin S. Choy, Steven R. Deitcher
Journal: Blood
Blood (2007) 110 (11): 1403.
https://doi.org/10.1182/blood.V110.11.1403.1403
Published: 2007